Vera Therapeutics VERA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -71.3%-20.6pp | -50.7%+22.5pp | -73.2%-18.4pp | -54.8%-15.3pp | -39.5%+5.3pp | |
| Return on invested capital | -77.1%-4.3pp | -72.8%+0.7pp | -73.5%-18.1pp | -55.4%-11.1pp | -44.3%+7.2pp | |
| Liquidity | ||||||
| Current ratio | 13.6×0.0× | 13.6×+1.4× | 12.2×-4.8× | 17×-10.7× | 27.7×+2.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.1×-0.1× | 0.2×0.0× | 0.2×+0.1× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $6.99-25.7% | $9.41+50.6% | $6.25-14.9% | $7.34-12.6% | $8.40-19.5% | |
| Valuation | ||||||
| Market capitalization | $2.87B-20.1% | $3.59B+93.8% | $1.85B+28.8% | $1.44B-6.0% | $1.53B-42.8% | |
| Price / book | 5.7×-0.2× | 5.9×+1.3× | 4.6×+1.6× | 3.1×+0.2× | 2.9×-1.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Vera Therapeutics's ratios come from?
- Every ratio is computed from Vera Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.